Screener
Aquestive Therapeutics, Inc. AQST Other — R&D
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The source filing: Aquestive Therapeutics, Inc.’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 4:10 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001398733-26-000042
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| AQST-108 project expenses | 152 | 190 | 710 | 385 |
| R&D other expenses: | ||||
| Personnel costs1 | 2,181 | 2,218 | 4,423 | 4,350 |
| Other2 | 574 | 493 | 893 | 1,039 |
| Total Research and Development Expenses | 3,962 | 4,105 | 8,166 | 9,466 |
| Selling expenses: | ||||
| Personnel costs3 | 1,730 | 608 | 3,374 | 1,302 |
| Other4 | 444 | 2,912 | 721 | 5,174 |
Item 1. FINANCIAL STATEMENTS (Unaudited)
FAQ
- What is Aquestive Therapeutics, Inc.'s other — R&D?
- Aquestive Therapeutics, Inc. (AQST) reported other — R&D of $574K in Q2 2026.
- How has Aquestive Therapeutics, Inc.'s other — R&D changed year-over-year?
- Aquestive Therapeutics, Inc.'s other — R&D increased by 16.4% year-over-year, from $493K to $574K.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s other — R&D?
- Over 2 years (2023 to 2025), Aquestive Therapeutics, Inc.'s other — R&D has grown at a 7.4% compound annual growth rate (CAGR), from $1.93M to $2.23M.
- What does other — R&D mean?
- This metric represents the costs incurred by the segment for scientific research and experimental development activities aimed at discovering or improving products. It captures the investment in innovation and pipeline advancement specifically allocated to this business unit. Monitoring this spend helps investors assess the segment's commitment to long-term product viability and technological differentiation.
Ask your AI about Aquestive Therapeutics, Inc.'s other — r&d.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude